Business ❯Pharmaceuticals
Stock Market Corporate Governance Drug Development Weight Loss Drugs Company Performance Leadership Leadership Changes Stock Performance Pharmaceutical Industry Obesity Epidemic
Lars Fruergaard Jørgensen will remain temporarily to ensure a smooth transition as the company faces intensified competition and market pressures.
